Update on the Use of Topical Calcineurin Inhibitors in Cutaneous Lupus Erythematosus

    February 2011 in “ Biologics: Targets & Therapy ”
    Michael Sticherling
    Image of study
    TLDR Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.
    The document from 2011 reviews the use of topical calcineurin inhibitors (TCIs), tacrolimus and pimecrolimus, in treating cutaneous lupus erythematosus (CLE). It compiles data from various small studies and case reports involving a total of 144 patients, showing that TCIs can be effective in treating CLE, particularly with 0.1% tacrolimus ointment. The effectiveness varies across CLE subsets, with systemic lupus erythematosus lesions responding well, while discoid lupus erythematosus lesions are less responsive. TCIs are well-tolerated with minimal side effects and do not cause skin atrophy, making them a promising alternative to corticosteroids. However, the document emphasizes the need for more extensive, controlled studies to establish evidence-based protocols for their use in CLE, as current clinical effects are limited to the duration of treatment. Concerns about the potential risk of skin malignancies with long-term use of TCIs are noted, but the document suggests that the risk may be overrated for CLE patients who follow strict UV protection guidelines.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 1000+ results
      If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      in Research  830 upvotes 1 year ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community Topical - Lantoprost .01%, MIN 10% DUT .05%, Hydrocortisone 1% Progrestron .025%

      in Treatment  5 upvotes 2 weeks ago
      A user was prescribed a topical treatment for hair loss including Latanoprost, Minoxidil, Dutasteride, Hydrocortisone, and Progesterone, after using an oral Minoxidil and Finasteride combo without significant results. Concerns were raised about the long-term use of hydrocortisone, with suggestions to consult a doctor regularly.

      community Topical finasteride carrier vehicle

      in Finasteride/Dutasteride  1 upvotes 1 day ago
      The user is using a topical solution containing 1% finasteride and 5% minoxidil for hair loss, with water, glycerin, and PEG-40 hydrogenated castor oil as carrier agents. They are questioning if these ingredients are effective carriers after using the solution for three months.

      community Topical finasteride 0.025% shedding

      in Finasteride/Dutasteride  3 upvotes 5 days ago
      A user is experiencing increased hair shedding after using a homemade topical finasteride mixture with stemoxydine for six weeks. They are concerned about whether the low dose could cause shedding so early.

      community Topical finasteride vs oral Dutasteride?

      in Finasteride/Dutasteride  7 upvotes 1 week ago
      Oral Dutasteride and topical Finasteride may have similar effects on scalp DHT, but topical Dutasteride might be less effective due to poor absorption. Combining oral Dutasteride with topical Finasteride could potentially enhance results by blocking DHT in both the scalp and serum.

    Similar Research

    5 / 1000+ results